Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Foot Rot D005535 1 associated lipids
Frostbite D005627 1 associated lipids
Strongyle Infections, Equine D013319 1 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Edema, Cardiac D004489 1 associated lipids
Osteoblastoma D018215 1 associated lipids
Radiculopathy D011843 1 associated lipids
Oligomenorrhea D009839 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Bluetongue D001819 1 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Gastric Dilatation D013271 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Stomach Volvulus D013277 1 associated lipids
Pulmonary Heart Disease D011660 2 associated lipids
Drowning D004332 2 associated lipids
Aortic Arch Syndromes D001015 2 associated lipids
Mixed Connective Tissue Disease D008947 2 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Yan Y et al. [Study on mechanism of eye-signs in blood stasis syndrome]. 1996 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:9206243
Gu YJ et al. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. 1996 J. Thorac. Cardiovasc. Surg. pmid:8751518
Krämer HJ et al. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. 1996 Biochem. Pharmacol. pmid:8937428
Fritsche KL and Cassity NA Metabolism of [3H]arachidonic acid by n-3 polyunsaturated fatty acid-enriched piglet alveolar macrophages. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8981628
Li KL et al. The effect of ketoprofen creams on periodontal disease in rhesus monkeys. 1996 J. Periodont. Res. pmid:8971650
Grauer GF et al. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs. 1996 Am. J. Vet. Res. pmid:8725828
Delatour P et al. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. 1996 Br. Vet. J. pmid:8680841
Jensen N et al. Recovery of endothelial cells and prostanoid production in endothelial cell-seeded grafts. 1996 Eur J Vasc Endovasc Surg pmid:8696898
Nosál R et al. The H1-histamine antagonist Dithiaden inhibits human platelets in vitro. 1996 Inflamm. Res. pmid:8696916
Taylor PM et al. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. 1996 Res. Vet. Sci. pmid:8685536
Janssen PL et al. Consumption of ginger (Zingiber officinale roscoe) does not affect ex vivo platelet thromboxane production in humans. 1996 Eur J Clin Nutr pmid:8933126
Klosterhalfen B et al. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. 1996 Biochem. Pharmacol. pmid:8937427
Liao CH et al. Antiplatelet effect of demethyldiisoeugenol. 1996 Can. J. Physiol. Pharmacol. pmid:9022830
Parnas BL et al. Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus. 1996 J. Nat. Prod. pmid:8904845
Berdeaux O et al. Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production. 1996 J. Lipid Res. pmid:8906600
Sheu JR et al. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. 1996 Eur. J. Pharmacol. pmid:9016940
Karck U et al. PGE2 and PGF2 alpha release by human peritoneal macrophages in endometriosis. 1996 Prostaglandins pmid:8900443
Blache D Enhanced arachidonic acid and calcium metabolism in cholesteryl sulfate-enriched rat platelets. 1996 J Lipid Mediat Cell Signal pmid:8925194
Pancera P et al. Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8860111
Pregnolato P et al. Effect of diets containing different amounts of precursor and derivative fatty acids on serum TXB2. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8981629
Lechi C et al. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid. 1996 Blood Coagul. Fibrinolysis pmid:8735820
Cirino G et al. Indomethacin and thromboxane A2/prostaglandin H2 antagonist SQ29,548 impair in vitro contractions of aortic rings of ex vivo-treated lipopolysaccharide rats. 1996 J Lipid Mediat Cell Signal pmid:8925198
Ziyyat A et al. Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. 1996 Br. J. Pharmacol. pmid:8886425
Sreedhara R et al. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. 1996 Am. J. Kidney Dis. pmid:8604704
Shibasaki T et al. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside. 1996 Am. J. Nephrol. pmid:8919236
Mustad V et al. Seasonal variation in parameters related to coronary heart disease risk in young men. 1996 Atherosclerosis pmid:8879440
Selley ML et al. The effect of cholesterol oxidation products on human platelet aggregation. 1996 Thromb. Res. pmid:8885139
Carbajal D et al. Possible cytoprotective mechanism in rats of D-002, an anti-ulcerogenic product isolated from beeswax. 1996 J. Pharm. Pharmacol. pmid:8887738
Nowak J et al. Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. 1996 Clin Physiol pmid:8842572
Baenkler HW et al. Eicosanoids from biopsy of normal and polypous nasal mucosa. 1996 Rhinology pmid:8938887
Huang JZ et al. Study on characteristics of blast-fragment combined injury in dogs. 1996 J Trauma pmid:8606426
Nishisho T et al. Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. 1996 Neurosurgery pmid:8905750
Giulian D et al. Activated microglia are the principal glial source of thromboxane in the central nervous system. 1996 Neurochem. Int. pmid:8808790
Zhen ZY et al. Experimental study on microthrombi and myocardial injuries. 1996 Microvasc. Res. pmid:8812763
Pace-Asciak CR et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. 1996 Clin. Chim. Acta pmid:8814965
Satterwhite JH and Boudinot FD Effects of age on the pharmacodynamics of naproxen in the rat. 1995 Sep-Oct Exp. Gerontol. pmid:8557098
Umeda F et al. Prostaglandins and diabetic nephropathy. 1995 Oct-Dec J. Diabetes Complicat. pmid:8573760
Stichtenoth DO et al. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. 1995 Nov-Dec Prostaglandins pmid:8838242
Muller M and Sorrell TC Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine. 1995 Nov-Dec Prostaglandins pmid:8838240
Fylling AC et al. Kinetic and structural evidence for the identification of 11-hydroxythromboxane B2 dehydrogenase as cytosolic aldehyde dehydrogenase. 1995 Nov-Dec Prostaglandins pmid:8838239
Saitta A et al. Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test. 1995 Jul-Aug Pharmacol. Res. pmid:8668647
Moreno A et al. Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats. 1995 Jul-Aug Haemostasis pmid:7557655
Eisenmann CJ and Miller RK Cadmium and glutathione: effect on human placental thromboxane and prostacyclin production. 1995 Jan-Feb Reprod. Toxicol. pmid:8520130
Keller F et al. Thromboxane B2 blood levels and incipient system clotting in heparin free hemodialysis. 1995 Apr-Jun ASAIO J. pmid:7640422
Kawamori R et al. Subclinical exocrine pancreatic derangement in human diabetic patients evaluated from pure pancreatic juice. 1995 Apr-Jun J. Diabetes Complicat. pmid:7541259
Zheng NX et al. Pharmacokinetic and pharmacodynamic studies of a thromboxane synthetase inhibitor, ozagrel, in rabbits. 1995 Biol. Pharm. Bull. pmid:8787798
Raptopoulos D et al. The effect of xylazine on plasma thromboxane B2 concentration in sheep. 1995 J. Vet. Pharmacol. Ther. pmid:8789696
Gomi T et al. Protective effect of thromboxane synthetase inhibitor on hypertensive renal damage in Dahl salt-sensitive rats. 1995 Clin Exp Pharmacol Physiol Suppl pmid:9072433
Anfossi G et al. Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. 1995 Thromb. Res. pmid:7778055
Kotamäki M Smoking induced differences in autonomic responses in military pilot candidates. 1995 Clin. Auton. Res. pmid:7780288
LÃ¥stbom L et al. Mechanisms of 3-carene-induced bronchoconstriction in the isolated guinea pig lung. 1995 Respiration pmid:7569332
Gil B et al. Effects of marine 2-polyprenyl-1,4-hydroquinones on phospholipase A2 activity and some inflammatory responses. 1995 Eur. J. Pharmacol. pmid:8575515
Butterly DW et al. Role of platelet activating factor in kidney transplant rejection in the rat. 1995 Kidney Int. pmid:7564100
Pratico D et al. Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha. 1995 J. Biol. Chem. pmid:7730359
Panara MR et al. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. 1995 Br. J. Pharmacol. pmid:8581280
Ingram AJ et al. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. 1995 Am. J. Kidney Dis. pmid:7847360
Malý J et al. Migraine--a haematological disorder? 1995 Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove pmid:8685625
Howarth SR et al. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels. 1995 Placenta pmid:8710799
Schierhorn K et al. Gelatin sponge-supported histoculture of human nasal mucosa. 1995 In Vitro Cell. Dev. Biol. Anim. pmid:7538857
Xiong YL and Zhao HY Effect of captopril on antithrombus function of endothelium. 1995 J. Tongji Med. Univ. pmid:8731927
Xiong YL and Zhao HY Experimental studies on preventive effects of API0134 on vessel reocclusion after thrombolysis. 1995 J. Tongji Med. Univ. pmid:8731957
Liang-min LD et al. [Effect of age on hemostasis and plasma level of TXB2 and 6-keto-PGF1 alpha]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732148
Fujimoto K et al. Neutrophil elastase inhibitor reduces asthmatic responses in allergic sheep. 1995 Respir Physiol pmid:7541545
Daugschies A Oesophagostomum dentatum: population dynamics and synthesis of prostanoids by histotropic stages cultured in vitro. 1995 Exp. Parasitol. pmid:8542999
Prisco D et al. Effect of n-3 fatty acid ethyl ester supplementation on fatty acid composition of the single platelet phospholipids and on platelet functions. 1995 Metab. Clin. Exp. pmid:7752902
Okano S et al. Effect of platelet activating factor antagonist (CV-3988) on 6-keto-PGF1 alpha and thromboxane B2 in dogs with experimental endotoxin-induced shock. 1995 J. Vet. Med. Sci. pmid:7756431
Nosál R et al. [The effect of antihistamines on stimulated blood platelet functions]. 1995 Cesk Fysiol pmid:7758143
Dodam JR and Olson NC Effect of fluoride on cardiopulmonary function and release of eicosanoids in pigs. 1995 J. Appl. Physiol. pmid:7759426
Balkhy HH et al. Comparison of Eurocollins and University of Wisconsin solution in single flush preservation of the ischemic reperfused lung: an in vivo rabbit model. 1995 Transplantation pmid:7732552
Patrignani P et al. Characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732817
Wang TL et al. The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: the role of antiplatelet therapy. 1995 Pacing Clin Electrophysiol pmid:8552510
Foegh ML et al. Urinary thromboxane has diagnostic value in myocardial infarction. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732879
Liu W et al. [Effects of selenium and vitamin E on arachidonic acid metabolism in experimental myocardial ischaemia]. 1995 Zhonghua Yu Fang Yi Xue Za Zhi pmid:8556938
Kohout M et al. Cool perfusion solutions for skin flaps: a new mixture of pharmacological agents which improves skin flap viability. 1995 Br J Plast Surg pmid:7735675
Kato A et al. Role of thromboxane A2 and prostacyclin in uninephrectomy-induced attenuation of ischemic renal injury. 1995 Kidney Int. pmid:8544417
Rasmanis G et al. Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction. 1995 Prostaglandins pmid:7667506
Murray MJ et al. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. 1995 Am. J. Physiol. pmid:8594921
Proppe DG et al. Diagnostic value of urinary thromboxane B2 concentration in detection of initial acute rejection reactions in human renal allografts. 1995 Transplantation pmid:7709445
Peaceman AM and Rehnberg KA The effect of aspirin and indomethacin on prostacyclin and thromboxane production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulant. 1995 Am. J. Obstet. Gynecol. pmid:7503174
Berti F et al. Protective effect of furosemide combined with non-steroidal anti-inflammatory drugs administered by inhalation route on guinea-pigs anaphylaxis model. 1995 Arzneimittelforschung pmid:8595068
Jesse RL et al. Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. 1995 Ann. N. Y. Acad. Sci. pmid:8597466
Myers SI et al. Regulation of eicosanoid synthesis in fibroblasts from inflamed gallbladders. 1995 Mol. Cell. Endocrinol. pmid:8674862
Horiguchi T et al. Heparin-protamine complexes cause pulmonary hypertension in goats. 1995 Anesthesiology pmid:7574058
Hotter G et al. Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. 1995 Transplantation pmid:7871573
Liu XH et al. [Study of anti-cerebral thromboembolism injection's activity on experimental arterial thrombosis and its therapeutical mechanism]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:7580067
Rho MC et al. Activation of rabbit platelets by Ca2+ influx and thromboxane A2 release in an external Ca(2+)-dependent manner by zooxanthellatoxin-A, a novel polyol. 1995 Br. J. Pharmacol. pmid:7582454
Wong HM et al. Role of calcium in thromboxane B2-mediated injury to rabbit gastric mucosal cells. 1995 Dig. Dis. Sci. pmid:7555460
Abran D et al. Mechanisms of the biphasic effects of peroxides on the retinal vasculature of newborn and adult pigs. 1995 Exp. Eye Res. pmid:7556492
Suzuki H et al. Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation. 1995 Exp. Mol. Pathol. pmid:7556592
Hespeling U et al. Stimulation of glycogen phosphorylase in rat hepatocytes via prostanoid release from Kupffer cells by recombinant rat anaphylatoxin C5a but not by native human C5a in hepatocyte/Kupffer cell co-cultures. 1995 FEBS Lett. pmid:7556629
Ko FN et al. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. 1995 Biochim. Biophys. Acta pmid:7548232
Stummer W et al. Cerebral protection against ischemia by locomotor activity in gerbils. Underlying mechanisms. 1995 Stroke pmid:7631348
VanderMeer TJ et al. Acute lung injury in endotoxemic pigs: role of leukotriene B4. 1995 J. Appl. Physiol. pmid:7775306
Li JX et al. Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia. 1995 Am. J. Med. Sci. pmid:7668305
Kawikova I et al. Bradykinin-induced release of thromboxane B2 into bronchoalveolar lavage fluid of guinea pigs: relationship to airflow obstruction. 1995 Eur. J. Pharmacol. pmid:8566097
Glaser K et al. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. 1995 Eur. J. Pharmacol. pmid:8566109
Altavilla D et al. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis. 1995 Eur. J. Pharmacol. pmid:8566149
Sorem KA and Siler-Khodr TM Placental prostanoid release in severe intrauterine growth retardation. 1995 Placenta pmid:8570572
Haugen G et al. Effect of phenazone (antipyrine) on the prostanoid formation in human umbilical arteries perfused in vitro. 1995 Gynecol. Obstet. Invest. pmid:7890260
Ding YA et al. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound. 1995 Thromb. Res. pmid:7740521